Manzo Pharmaceuticals, Inc.

MNZO · OTC
Analyze with AI
9/30/2005
12/31/2004
9/30/2004
Assets
Cash & Equivalents$7$10
Short-Term Investments$0$0
Receivables$2,679$0
Inventory$0$0
Other Curr. Assets$499$138
Total Curr. Assets$3,184$148
Property Plant & Equip (Net)$805$1,142
Goodwill$0$0
Intangibles$0$0
Long-Term Investments$0$0
Tax Assets$0$0
Other NC Assets$59$0
Total NC Assets$863$1,142
Other Assets$0$0
Total Assets$4,048$1,290
Liabilities
Payables$161$405
Short-Term Debt$5,120$6,523
Tax Payable$3,621$1,487
Deferred Revenue$0$0
Other Curr. Liab.$177$1,781
Total Curr. Liab.$15,787$23,793
LT Debt$0$0
Deferred Rev, NC$0$0
Deferred Tax Liab, NC$0$0
Other NC Liab.$0$0
Total NC Liab.$0$0
Other Liabilities$0$0
Cap. Leases$0$0
Total Liabilities$15,787$23,793
Equity
Pref Stock$0$0
Common Stock$52$35
Retained Earnings-$22,581-$31,371
AOCI-$28-$24
Other Equity$0$0
Total Equity-$11,739-$22,503
Supplemental Information
Minority Interest$0$0
Total Liab. & Tot. Equity$4,048$1,290
Net Debt$5,114$6,513$0